Second Hospital of Hebei Medical University
Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 2 | 2026-09-01 | NCT07796516 | |
| A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Not yet recruiting | Phase 2 | 2026-08-12 | NCT07760155 | |
| Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort | acute myocardial infarction | Recruiting | Not stated | 2025-09-03 | NCT05862103 | |
| Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke | Mild Stroke | Recruiting | Phase 4 | 2025-07-31 | NCT07095790 |